RT Journal Article
SR Electronic
A1 Buckley, Rita
T1 NAFLD: CV Risk Regardless of Hyperglycemia or Obesity
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 11
SP 12
OP 13
DO 10.1177/155989771111006
UL http://mdc.sagepub.com/content/11/11/12.abstract
AB The prevalence of nonalcoholic fatty liver disease (NAFLD) has been estimated to be between 20% and 30% in the general population, but this value is much higher (approximately 70% to 80%) in individuals with type 2 diabetes. Increasing recognition of NAFLD and its strong relationship with metabolic syndrome has stimulated an interest in its possible role in the development of cardiovascular disease [Targher G et al. Diabetologia 2008].